Quick Comparison
| Topic | Semax | Selank | Plain-language difference |
|---|---|---|---|
| Molecular origin | ACTH-fragment-derived peptide | Tuftsin-related peptide | They come from different peptide research lines. |
| Common research areas | Neurotrophic and gene-expression measurements | GABA-related and gene-expression measurements | The investigated signals and study histories differ. |
| Evidence | Laboratory, animal and limited human research | Laboratory, animal and limited human research | Neither evidence base establishes outcomes for a Ryse product. |
Quick comparison
The shared fact that both appear in neuroscience literature does not make their structures, targets or evidence interchangeable.
- Semax: synthetic heptapeptide developed from an ACTH-related sequence
- Selank: synthetic tuftsin-related heptapeptide
- Both: studied in laboratory, animal and limited human settings
- Neither: FDA approved as a drug in the United States
Different molecular origins
Semax was developed from research involving a short ACTH-related fragment. It is not full-length ACTH and should not be represented as reproducing all ACTH biology.
Selank is related to tuftsin, a short peptide associated with immune-related research. Its origin and sequence differ from Semax.
Research questions
Semax publications include neurotrophic, BDNF-related, gene-expression and brain-network measurements. Selank publications include tuftsin-related biology, GABA-related measurements, gene expression and behavioral models.
These are categories of investigation. A measured molecular or behavioral marker does not establish a generalized cognitive, mood or clinical outcome.
What are the limits of the current evidence?
Human publications exist for both compounds, but the evidence is limited, often formulation-specific, geographically concentrated or not independently replicated. Small imaging or rating-scale studies cannot establish broad effectiveness or equivalence to a Ryse material.
Why analytical identity matters
Similar catalog context is not chemical identity. Researchers should verify the exact product name, lot and analytical documentation, and should keep purity results separate from identity evidence.
Frequently asked questions
Are Semax and Selank the same peptide?
No. Their sequences, molecular origins and research histories are different.
Which one is better?
This research guide does not rank compounds or recommend personal use. The available studies address different questions and cannot support that comparison.
Do human studies establish outcomes?
No. Human evidence is limited and does not establish outcomes for Ryse research products.